Dabigatran reduces major CV complications in patients with myocardial injury after noncardiac surgery
ORLANDO (March 11, 2018) -- Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart attack, stroke and other heart or blood-vessel...









